Article
The use of human immunodeficiency virus resistance tests in clinical practice.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases - 1 Oct 2010
Ceccherini-Silberstein F, Cento V, Calvez V, Perno C-F
Abstract excerpt
Important progress has been made in recent years in the development and clinical use of drugs for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Nevertheless, when antiretroviral therapy fails to be fully suppressive, new viral variants emerge, thus allowing HIV-1 to escape from drug pressure by accumulating mutations. Between 50% and 70% of treated patients with virological rebound...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
